Boston Scientific brings spinal cord stimulators to U.S. market — 4 things to know

Medical device company Boston Scientific launched its WaveWriter Alpha spinal cord stimulator systems in the U.S., according to a Jan. 14 news release.

Advertisement

Four things to know:

1. WaveWriter has four MRI implantable pulse generators that allow personalized treatment based on the patient’s needs. It offers access to waveforms that cover many areas of chronic pain.

2. The device layers paraesthesia and paraesthesia-free options simultaneously to target nerves along the spinal cord.

3. WaveWriter is indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including pain associated with failed spine surgery syndrome.

4. The system launched in Europe in September and received FDA approval in December.

More articles on devices:
‘It’s changed my whole practice’: Orthopedic chief lauds impact of robotic surgery
Hackers attempt to divert funds from spine practice: 3 details
Stryker, Smith+Nephew seal 1st acquisitions of 2021: 7 device company notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.